Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diffusion Pharmaceuticals Inc (DFFN)

Diffusion Pharmaceuticals Inc (DFFN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diffusion Pharmaceuticals Inc 300 East Main Street Suite 201 CHARLOTTESVILLE VA 22902 USA

www.diffusionpharma.com P: 434-220-0718

Description:

Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant solid tumors. Diffusion Pharmaceuticals Inc., formerly known as RestorGenex Corporation, is based in Charlottesville, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,977
Enterprise Value, $K -13,543
Shares Outstanding, K 2,040
Annual Sales, $ 0 K
Annual Net Income, $ -15,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,110 K
60-Month Beta 1.78
% of Insider Shareholders 1.80%
% of Institutional Shareholders 9.95%
Float, K 2,004
% Float 98.20%
Short Volume Ratio 0.49

Growth:

1-Year Return -36.23%
3-Year Return -92.07%
5-Year Return -98.53%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.04 on 08/08/23
Latest Earnings Date 08/10/23
Earnings Per Share ttm -2.41
EPS Growth vs. Prev Year 49.51%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-3 on 08/17/23

DFFN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.96%
Return-on-Assets % -62.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.63
Book Value/Share 6.98
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar